Ken Fisher Sutro Biopharma, Inc. Transaction History
Fisher Asset Management, LLC
- $243 Billion
- Q3 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 271,337 shares of STRO stock, worth $686,482. This represents 0.0% of its overall portfolio holdings.
Number of Shares
271,337
Previous 271,337
-0.0%
Holding current value
$686,482
Previous $795,000
17.99%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding STRO
# of Institutions
136Shares Held
62.4MCall Options Held
77.1KPut Options Held
31.4K-
Suvretta Capital Management, LLC New York, NY7.19MShares$18.2 Million0.98% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$17.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.2MShares$10.6 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3MShares$7.58 Million0.03% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.83MShares$7.17 Million1.53% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $132M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...